183 related articles for article (PubMed ID: 2410107)
1. Bovine leukemia virus, a versatile agent with various pathogenic effects in various animal species.
Burny A; Bruck C; Cleuter Y; Couez D; Deschamps J; Ghysdael J; Grégoire D; Kettmann R; Mammerickx M; Marbaix G
Cancer Res; 1985 Sep; 45(9 Suppl):4578s-4582s. PubMed ID: 2410107
[TBL] [Abstract][Full Text] [Related]
2. Bovine leukemia virus, a distinguished member of the human T-lymphotropic virus family.
Burny A; Bruck C; Cleuter Y; Couez D; Deschamps J; Ghysdael J; Gregroire D; Kettmann R; Mammerickx M; Marbaix G
Princess Takamatsu Symp; 1984; 15():219-27. PubMed ID: 6100641
[TBL] [Abstract][Full Text] [Related]
3. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
[TBL] [Abstract][Full Text] [Related]
4. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP
Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
[TBL] [Abstract][Full Text] [Related]
5. Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer.
Burny A; Cleuter Y; Kettmann R; Mammerickx M; Marbaix G; Portetelle D; Van den Broeke A; Willems L; Thomas R
Cancer Surv; 1987; 6(1):139-59. PubMed ID: 2891439
[TBL] [Abstract][Full Text] [Related]
6. Heteroduplex mapping in the molecular analysis of the human T-cell leukemia (lymphotropic) viruses.
Gonda MA; Wong-Staal F; Gallo RC; Clements JE; Gilden RV
Cancer Res; 1985 Sep; 45(9 Suppl):4553s-4558s. PubMed ID: 2990686
[TBL] [Abstract][Full Text] [Related]
7. Retroviruses as carcinogens and pathogens: expectations and reality.
Duesberg PH
Cancer Res; 1987 Mar; 47(5):1199-220. PubMed ID: 3028606
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of human T-lymphotropic retroviruses.
Wong-Staal F; Ratner L; Shaw G; Hahn B; Harper M; Franchini G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4539s-4544s. PubMed ID: 2990683
[TBL] [Abstract][Full Text] [Related]
9. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
[TBL] [Abstract][Full Text] [Related]
10. [Molecular biology of human T-lymphotropic retroviruses (HTLV)].
Dorner F; Barrett PN; Schmidt BL; Bodemer W
Wien Med Wochenschr; 1986 Apr; 136(7-8):181-8. PubMed ID: 2425498
[TBL] [Abstract][Full Text] [Related]
11. Subunit vaccines against exogenous retroviruses: overview and perspectives.
Hunsmann G
Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114
[TBL] [Abstract][Full Text] [Related]
12. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat.
Katoh I; Yoshinaka Y; Sagata N; Ikawa Y
Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987
[TBL] [Abstract][Full Text] [Related]
13. [Transactivation of the long terminal repeat promoter of the bovine leukemia virus in infected cells].
Bychko VV; Pumpen PP; Aprelikova ON; Mikhaĭlov VM; Tomilin NV
Dokl Akad Nauk SSSR; 1986; 286(1):221-3. PubMed ID: 3004866
[No Abstract] [Full Text] [Related]
14. Bovine leukemia: facts and hypotheses derived from the study of an infectious cancer.
Burny A; Cleuter Y; Kettmann R; Mammerickx M; Marbaix G; Portetelle D; Van den Broeke A; Willems L; Thomas R
Adv Vet Sci Comp Med; 1988; 32():149-70. PubMed ID: 2847501
[TBL] [Abstract][Full Text] [Related]
15. Bovine leukaemia virus and enzootic bovine leukosis.
Burny A; Bruck C; Cleuter Y; Couez D; Deschamps J; Gregoire D; Ghysdael J; Kettmann R; Mammerickx M; Marbaix G
Onderstepoort J Vet Res; 1985 Sep; 52(3):133-44. PubMed ID: 3003647
[TBL] [Abstract][Full Text] [Related]
16. [Infection of peripheral blood lymphocytes in sheep with bovine leukemia virus in vitro].
Banders UT; Meldraĭs EI; Sauka EI; Razena LG; Line IE
Mol Gen Mikrobiol Virusol; 1989 Jan; (1):25-9. PubMed ID: 2543921
[TBL] [Abstract][Full Text] [Related]
17. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
18. BLV and HTLV-I: their unique genomic structures and evolutionary relationship.
Sagata N; Ikawa Y
Princess Takamatsu Symp; 1984; 15():229-40. PubMed ID: 6085845
[TBL] [Abstract][Full Text] [Related]
19. [A new HTLV retrovirus associated with human T-cell leukemia/lymphoma].
Kiselev FL
Eksp Onkol; 1984; 6(3):3-9. PubMed ID: 6094144
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF
J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
